CIDARA THERAPEUTICS
Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics. The company focuses on developing innovative therapies to treat life-threatening illnesses exacerbated by deficiencies of the human immune system. Cidara Therapeutics was founded in 2012 and headquartered in San Diego, California.
CIDARA THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2012-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.cidara.com
Total Employee:
51+
Status:
Active
Contact:
858-230-8519
Email Addresses:
[email protected]
Total Funding:
156.06 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
858 Therapeutics
858 Therapeutics is a stealth company specializing in the area of healthcare services, pharmaceutical, and biotechnology.
Adaptive Symbiotic Technologies
Adaptive Symbiotic Technologies is a biotechnology company that specializes in the fields of agriculture and farming.
Asher Bio
Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.
Biofourmis
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics.
Capricor Therapeutics
Capricor Therapeutics is a biotechnology company focusing on cell and exosome-based therapeutics.
Cayman Chemical
Cayman Chemical is a biotechnology firm that provides assay kits, antibodies, proteins, biochemicals, and contract services.
CB Therapeutics
CB Therapeutics is a biotech company that specializes in the biosynthetic production of cannabinoids from sugar.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Children's Therapeutic Strategies
Children's Therapeutic Strategies is a company specialized in individual, family therapy infant mental health and trauma therapy services.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
EnginZyme
EnginZyme is a biotechnology company that specializes in biocatalysis.
Flexion Therapeutics
Flexion Therapeutics is a biotechnology company that develops long-lasting intra-articular injection therapies to treat osteoarthritis.
GeneThera
GeneThera is a biotechnology company, dedicated to improving food safety by applying the latest molecular technologies
Iksuda Therapeutics
Iksuda Therapeutics is a biotechnology company specializing in the development of next generation biotherapeutics
Gross-Wen Technologies
Gross-Wen Technologies is a biotechnology company that specializes in the fields of water quality, wastewater, and water nitrogen.
HelioBioSys
HelioBioSys is a biotechnology company that specializes in marine cyanobacteria.
Heron Therapeutics
Heron Therapeutics is a biotechnology firm specializing in polymer-based pharmaceuticals.
Implanet
Implanet is a biotechnology company that provides implants for healthcare professionals treating orthopaedic patients.
Intelligent Sensory concept
Biolux Medical is biotechnology company that specializes in photomodulation.
Joylux
Joylux is a health and wellness company that specializes in women's health and wellness.
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Pasithea Therapeutics
Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health.
Plakous Therapeutics
Plakous Therapeutics is a human biologics company that specializes in restorative and regenerative healing.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Seer
Seer is a medical technology company that specializes in addressing neurological conditions.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
UVLrx Therapeutics
UVLrx Therapeutics is a biotechnology company that specializes in the fields of medical, healthcare, and therapeutics.
Verenium
Verenium is an industrial biotechnology company specializing in the development of high performance enzymes.
Vystar
Vystar is a publicly-traded biotechnology company that is engaged in the rubber and plastic products market.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Cidara Therapeutics
CARB-X
CARB-X investment in Grant - Cidara Therapeutics
Square 1 Bank
Square 1 Bank investment in Post-IPO Debt - Cidara Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Cidara Therapeutics
Sabby Capital
Sabby Capital investment in Series B - Cidara Therapeutics
venBio Partners
venBio Partners investment in Series B - Cidara Therapeutics
5AM Ventures
5AM Ventures investment in Series B - Cidara Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Series B - Cidara Therapeutics
Aisling Capital
Aisling Capital investment in Series B - Cidara Therapeutics
Fidelity
Fidelity investment in Series B - Cidara Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-01 | Cidara Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Financial Officer and Chief Business Officer, and Shane Ward as Chief Legal Officer and Corporate Secretary |
Official Site Inspections
http://www.cidara.com Semrush global rank: 509.98 K Semrush visits lastest month: 96.68 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cidara Therapeutics"
Targeted Immunotherapy for Transformative …
Contact Us. Cidara Therapeutics, Inc. 6310 Nancy Ridge Drive, Suite 101 San Diego, CA 92121. p: (858) 752-6170 e: [email protected]See details»
Corporate Governance - Cidara Therapeutics
As Senior Vice President of the commercial organization, Mr. Spencer led the successful commercial launch of the industry’s first and only two-dose hepatitis B vaccine – HEPLISAV …See details»
Cidara Therapeutics - Crunchbase Company Profile & Funding
Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics. The company focuses on developing innovative therapies to treat life-threatening …See details»
Cidara Therapeutics, Inc. - Devex
Learn more about Cidara Therapeutics, Inc.'s jobs, projects, latest news, contact information and geographical presence. Cidara is developing long-acting therapeutics designed to improve the ...See details»
Cidara Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
Cidara is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases that are inadequately …See details»
Cidara Therapeutics - LinkedIn
Cidara Therapeutics is a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of ...See details»
Cidara Therapeutics Provides Corporate Update and Reports
Nov 8, 2024 Cidara Therapeutics is using its proprietary Cloudbreak ® platform to develop novel drug-Fc conjugates (DFCs) comprising targeted small molecules or peptides coupled to a …See details»
Cidara Therapeutics Announces Appointment of Jim Beitel as Chief ...
Aug 19, 2024 The Cidara Therapeutics, Inc. 2020 Inducement Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Cidara, or …See details»
Cidara Therapeutics Company Profile - Office Locations ... - Craft
Oct 29, 2024 Cidara Therapeutics has 4 employees at their 1 location and $63.91 m in annual revenue in FY 2023. See insights on Cidara Therapeutics including office locations, …See details»
Cidara Therapeutics Announces $105 Million Private Placement
Nov 21, 2024 Financing led by new investor, Venrock Healthcare Capital Partners, with significant participation by new and existing life sciences-focused investorsSAN DIEGO, Nov. …See details»
Working at Cidara Therapeutics - Zippia
Mar 14, 2024 Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics. The company focuses on developing innovative therapies to treat …See details»
Investors - Cidara Therapeutics
Nov 19, 2024 Contact Us. Cidara Therapeutics, Inc. 6310 Nancy Ridge Drive, Suite 101 San Diego, CA 92121. p: (858) 752-6170 e: [email protected]See details»
Cidara Therapeutics Provides Corporate Update and Reports Third …
Press Releases Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsSee details»
How Cidara Got Its Molecule Back - bioprocessonline.com
Oct 30, 2024 Jeffrey Stein, Ph.D., President & CEO, Cidara Cidara President & CEO Jeff Stein, Ph.D. tells me that under its agreement with Janssen, Cidara was responsible for executing on …See details»
Cidara Therapeutics Named as a San Diego Metro Area Top …
Nov 20, 2023 Cidara was among the top 100 companies and organizations included in the 2023 Top Workplace list. ... The confidential survey uniquely measured 15 culture drivers that are …See details»
Cidara Therapeutics Provides Corporate Update and Reports
Jul 11, 2024 Cidara’s lead DFC candidate, CD388, is a long-acting antiviral designed to achieve universal prevention of seasonal and pandemic influenza with a single dose by directly …See details»
Cidara Overview October 2021 - Cidara Therapeutics
Cidara's Form 10-K as most recently filed with the United States Securities and Exchange Commission ("SEC“’) under the heading “Risk Factors.” Additional risks and uncertainties may …See details»
Cidara: Potential To Change Flu Prophylaxis Landscape With CD388
Nov 21, 2024 According to the 10-Q SEC Filing, Cidara Therapeutics had cash and cash equivalents of $127.4 million as of September 30th of 2024. The reason for the cash on hand …See details»
Newsroom - Cidara Therapeutics
Oct 4, 2024 How Cidara Got Its Molecule Back Oct 30, 2024 Cidara buys back flu rights, sells antifungal and inks $240M PIPE Apr 24, 2024 ... Although there is no such thing as a truly …See details»